Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
For 2020, 28 EU/EEA countries reported 4 824 confirmed cases of Shiga toxin -producing Escherichia coli (STEC) infection. The overall notification rate was 1.6 cases per 100 000 population. The highest notification rates were reported in Ireland, Malta, Denmark, and Norway. The EU/EEA notification rate decreased notably in 2020 compared with 2016-2019 due to the COVID-19 pandemic.
Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. For 2020, 29 EU/EEA countries reported 1 806 confirmed shigellosis cases.
This document assesses the risk of further spread of S. sonnei amongst MSM and in the broader population in EU/EEA countries, resulting from the current increase in extensively-drug resistant S. sonnei infections.
This report presents the results of the 10th round of the external quality assessment (EQA-10) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 July 2021 and includes updates on Escherichia coli ST38, COVID-19, Vibrio growth in the Baltic Sea the Olympic Games in Tokyo 2020 (2021), West Nile virus, avian influenza and cholera.
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.